
GSK is reportedly to sell its Lucozade and Ribena brands to Osaka-based Suntory in a deal worth up to £1.5 …
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics

